![](https://img.medscapestatic.com/vim/live/professional_assets/medscape/images/thumbnail_library/dt_240716_semaglutide_pen_800x450.jpg)
GLP-1s Don't Increase Neurologic, Psychiatric Risk
An analysis based on a massive database of US electronic health records (EHRs) adds to evidence favoring the safety of glucagon-like peptide 1 (GLP-1) medications, finding no increased risk for many neurologic and psychiatric ailments when semaglutide was …